These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 27810704

  • 41. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
    Shamshiri H, Paragomi P, Paydar MJ, Moezi L, Bahadori M, Behfar B, Ardalan FA, Dehpour AR.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
    [Abstract] [Full Text] [Related]

  • 42. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.
    Tamaoki S, Yamauchi Y, Nakano Y, Sakano S, Asagarasu A, Sato M.
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1315-23. PubMed ID: 17540858
    [Abstract] [Full Text] [Related]

  • 43. EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.
    Nozu T, Miyagishi S, Nozu R, Ishioh M, Takakusaki K, Okumura T.
    J Pharmacol Sci; 2021 Jul; 146(3):121-124. PubMed ID: 34030794
    [Abstract] [Full Text] [Related]

  • 44. [Antagonists of the type 3 serotonin receptor (5 -HT3) in IBS].
    Komoto S, Miura S.
    Nihon Rinsho; 2006 Aug; 64(8):1487-90. PubMed ID: 16898618
    [Abstract] [Full Text] [Related]

  • 45. Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer.
    Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K.
    Neurogastroenterol Motil; 2008 May; 20(5):557-65. PubMed ID: 18221252
    [Abstract] [Full Text] [Related]

  • 46. Peripheral α-helical CRF (9-41) does not reverse stress-induced mast cell dependent visceral hypersensitivity in maternally separated rats.
    van den Wijngaard RM, Stanisor OI, van Diest SA, Welting O, Wouters MM, de Jonge WJ, Boeckxstaens GE.
    Neurogastroenterol Motil; 2012 Mar; 24(3):274-82, e111. PubMed ID: 22129370
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T, Okumura T.
    J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
    Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T.
    Sci Rep; 2019 Dec 20; 9(1):19603. PubMed ID: 31862976
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.
    Lv Y, Wen J, Fang Y, Zhang H, Zhang J.
    Peptides; 2022 Jan 20; 147():170705. PubMed ID: 34822913
    [Abstract] [Full Text] [Related]

  • 53. Inhibitory effects of SKI3246, the rhizome extract of Atractylodes japonica, on visceral hypersensitivity in experimental irritable bowel syndrome rat models.
    Son HJ, Jung K, Park YH, Jeon HJ, Kang M, Ryu KH, Pyo SS, Eutamene H, Bueno L, Sun WS.
    Arch Pharm Res; 2015 Jan 20; 38(5):642-9. PubMed ID: 25070763
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.
    Taché Y, Martinez V, Wang L, Million M.
    Br J Pharmacol; 2004 Apr 20; 141(8):1321-30. PubMed ID: 15100165
    [Abstract] [Full Text] [Related]

  • 57. Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice.
    Barone FC, Barton ME, White RF, Legos JJ, Kikkawa H, Shimamura M, Kuratani K, Kinoshita M.
    Pharmacology; 2008 Apr 20; 81(1):11-7. PubMed ID: 17726343
    [Abstract] [Full Text] [Related]

  • 58. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA, Almeida J, Benini R, Crestani CC.
    Pharmacol Res; 2015 Apr 20; 95-96():53-62. PubMed ID: 25829333
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.